Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MindBio Therapeutics Corp. C.MBIO

MindBio Therapeutics Corp is a pioneering clinical stage biotechnology company that specializes in developing psychedelic microdosing treatments for mental health conditions. MindBio has obtained government and regulatory approvals for at-home LSD microdosing in clinical trials, making it the only organization in the world to do so.

CSE:MBIO - Post Discussion

MindBio Therapeutics Corp. > Beware the Aussie Bullies
View:
Post by MrForthright on May 18, 2024 5:10pm

Beware the Aussie Bullies

They are promoting broke companies like $MBIO and $SPAI. Stay away
Comment by Smokey1958 on May 20, 2024 12:46pm
How is MBIO broke? How many aliases do you have? Where is the evidence? MBIO has the following going for it so it ain't broke, genius: * it's a startup ....so of course it has more liabilities than monetary assets * it has world class researchers carrying out the clinical trials * research is funded publicly (listed), by governments and through research grants * MBIO is on par or ...more  
Comment by MrForthright on May 20, 2024 3:40pm
Broke = see www.sedarplus.com, all there
Comment by Smokey1958 on May 20, 2024 5:58pm
You might want to (a) read the whole report on sedar (b) consider the conversion of a major loan to shares (as requested by the lender) (c)  understand it's an early stage pharma company which in the words of one of the researchers involved is involved in "research that punches way above their weight" and (d) alternative sources of funding to the researchers, including the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities